| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Bioxyne Limited (AU: BXN)
BXN Technical Analysis
1
| As on 27th Aug 2024 BXN STOCK Price closed @ 0.01 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BXNSTOCK Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | N/A | N/A |
| Low | 0.01 | 1 Week | 0.00 | 0.00 |
| Close | 0.01 | 1 Month | 0.00 | 0.00 |
| Volume | 1492647 | 1 Year | 0.00 | 0.00 |
| 52 Week High 0.00 | 52 Week Low 0.00 | ||||
AU Australia Most Active Stocks
| SYA | 0.03 | % |
| M2R | 0.01 | % |
| ACW | 0.04 | % |
| QPM | 0.04 | % |
| BCB | 0.01 | % |
| YAL | 5.35 | % |
| RED | 0.36 | % |
| LRS | 0.22 | % |
| NAG | 0.02 | % |
| STX | 0.20 | % |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| BXN Daily Charts |
BXN Intraday Charts |
Whats New @ Bazaartrend |
BXN Free Analysis |
|
|
BXN Important Levels Intraday
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
| SUPPORT | 0.00 |
BXN Forecast September 2024
| 4th UP Forecast | 0 |
| 3rd UP Forecast | 0 |
| 2nd UP Forecast | 0 |
| 1st UP Forecast | 0 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | 0 |
BXN Weekly Forecast
| 4th UP Forecast | 0.00 |
| 3rd UP Forecast | 0.00 |
| 2nd UP Forecast | 0.00 |
| 1st UP Forecast | 0.00 |
| 1st DOWN Forecast | 0.00 |
| 2nd DOWN Forecast | 0.00 |
| 3rd DOWN Forecast | 0.00 |
| 4th DOWN Forecast | 0.00 |
BXN Forecast2024
| 4th UP Forecast | 0 |
| 3rd UP Forecast | 0 |
| 2nd UP Forecast | 0 |
| 1st UP Forecast | 0 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | 0 |
| 4th DOWN Forecast | 0 |
Bioxyne Limited ( AU Australia Symbol : BXN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BXN Business Profile
Bioxyne Limited, a life sciences and health products company, researches, develops, manufactures, markets, and distributes dietary supplement and beauty products. The company operates in two segments, Wholesale Sales and Direct Sales. It engages in developing a range of functional foods and beauty products. The company's products portfolio includes BK18, a dairy-based drink; Allura, a beauty and body shake for women's; Mustang, a nutritional shake to support fat and energy metabolism with prebiotic fiber; Mymana, a colostrum-based food product that supports energy, digestive, and immune functions, and honey powder; and BEssence, an anti-ageing serum. In addition, it offers its foaming and toning cleanser, repair oils, probiotic dietary supplements under the Progastrim name. The company provides its products online, as well as through wholesale or direct sales in Australia, the United States, New Zealand, and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia. Address: 50 Clarence Street, Sydney, NSW, Australia, 2000
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service